Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab

J Am Acad Dermatol. 2021 Apr;84(4):e197-e198. doi: 10.1016/j.jaad.2020.10.075. Epub 2020 Oct 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Immunologic Factors
  • Pandemics
  • Pemphigus* / drug therapy
  • Pemphigus* / epidemiology
  • Rituximab / therapeutic use
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • Immunologic Factors
  • Rituximab